Viewing Study NCT01755195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:47 PM
Ignite Modification Date: 2026-02-24 @ 12:25 AM
Study NCT ID: NCT01755195
Status: COMPLETED
Last Update Posted: 2024-01-03
First Post: 2012-12-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Cabozantinib for Adults With Advanced Soft Tissue Sarcoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Soft Tissue Sarcomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dual Inhibitor of MET and VEGFR View
None XL184 View
None Metastatic Refractory View
None Soft Tissue Sarcoma View
None Rare Heterogeneous Tumor View